Oxytocin and Cognitive Control in Adult ADHD

Clinical trial NCT03136263 · COMPLETED

Trial details

NCT number: NCT03136263
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Attention Deficit/Hyperactivity Disorder

Start date: 2017-12-14
Primary completion: 2020-11-05
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.